EZH2 and hepatocellular carcinoma: Collectively, These findings collectively suggest that NCTD exerts its anti-tumor effects via directly targeting to EZH2 and modulating the interaction between EZH2 and PP1, thereby potentially influencing tumor progression pathways in HCC.